“…Childhood nasopharyngeal cancer comprise of 7.2% in Turkey, whereas 1-2% in China, 2.4% in UK, 10% in USA, 12% in Israel, 13% in Kenya, 14.5% in Tunisia, and 18% in Uganda [1,4,[7][8][9][31][32][33][34]. Twenty-four percent crude rate of our institutionally treated nasopharynx patients were 30 years old, mainly owing to being a tertiary reference center.…”